Related Experiment Video
Updated: Aug 14, 2026

Laminectomy for the Removal of Thoracic Ossification of the Ligamentum Flavum (TOLF) Using Ultrasonic and Conventional Osteotomes
Published on: April 21, 2023
The Main Immune Markers of Ligamentum Flavum Hypertrophy: A Narrative Literature Review
Domantas Tamasauskas1,2, Laura Tamasauskiene1,3, Brigita Gradauskiene1
1Department of Immunology and Allergology, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50009 Kaunas, Lithuania.
Abstract:
LF hypertrophy contributes to the narrowing and compression of neural structures, impairing limb function. It is a leading cause of spinal stenosis, particularly in the lumbar region. About 20% of those over 60 show lumbar stenosis on imaging, but over 80% have no symptoms. Surgery is the main treatment option and is only recommended for symptomatic cases. The exact cause of LF hypertrophy remains unclear, though chronic inflammation, fibrosis and oxidative stress are implicated. Research consistently shows that increased cytokines and growth factors drive extracellular matrix remodeling, immune cell infiltration, and fibroblast and osteoblast activation. The aim of this article is to briefly review the role of the main immune markers that are involved in the pathogenesis of LF hypertrophy. This narrative review is based on a PubMed literature search and includes 23 original articles published between 2019 and 2026.
Related Concept Videos
Chronic Inflammation: Introduction
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
